Central Asian Research Index

Tibbiyot, ta’lim va innovatsion tadqiqotlar, 2026, т. 2, № 11, с. 62-69

METABOLIK SINDROMDA YURAKNING ERTA STRUKTURAVIY VA FUNKSIONAL OʻZGARISHLARI: DIFFUZ MIOKARD FIBROZIDAN OTISH FRAKSIYASI SAQLANGAN YURAK YETISHMOVCHILIGIGACHA

Farrux Abdurashitovich Zikrillayev

Аннотация · Abstract

The aim of this study was to evaluate early structural and functional cardiac changes, particularly diffuse myocardial fibrosis, in patients with metabolic syndrome (MetS) without clinical signs of heart failure. This cross-sectional observational study enrolled 360 participants: patients with MetS without diastolic dysfunction (n=140), patients with MetS and diastolic dysfunction (n=120), and a control group (n=100). All participants underwent speckle-tracking echocardiography, cardiac magnetic resonance imaging with T1 mapping and extracellular volume (ECV) quantification, and biomarker assessment (hs-cTnT, NT-proBNP, galectin-3, sST2). Native T1 values and ECV increased stepwise from the control group (1018 ± 25 ms; 26.2 ± 2.1%) to the asymptomatic MetS group (1058 ± 33 ms; 29.1 ± 3.2%) and the MetS group with diastolic dysfunction (1082 ± 38 ms; 31.4 ± 3.8%; p

Сведения · Details